OXT and post-traumatic stress disorder: Nawijn et al. (2016) showed that intranasal oxytocin could potentially reduce anhedonia related symptoms of reward processing in patients with PTSD, suggesting that intranasal oxytocin could also be useful for augmenting clinical psychotherapy sessions.